nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Metolazone—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Metolazone—Anaemia—Etoposide—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Metolazone—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00122	0.00122	CcSEcCtD
Metolazone—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Metolazone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Metolazone—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00121	0.00121	CcSEcCtD
Metolazone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Metolazone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Metolazone—Insomnia—Vincristine—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Metolazone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Metolazone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Metolazone—Malaise—Etoposide—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Metolazone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Metolazone—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Metolazone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Metolazone—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Metolazone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Metolazone—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Metolazone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Metolazone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Metolazone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Metolazone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Metolazone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Metolazone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Metolazone—Rash—Topotecan—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Metolazone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Cough—Etoposide—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Headache—Topotecan—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Rash—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Metolazone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Headache—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Constipation—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Pain—Vincristine—peripheral nervous system neoplasm	0.00114	0.00114	CcSEcCtD
Metolazone—Rash—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Metolazone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Metolazone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Metolazone—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Metolazone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Metolazone—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Metolazone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Metolazone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Metolazone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Metolazone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Metolazone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Metolazone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Metolazone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Metolazone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Metolazone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Metolazone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00108	0.00108	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Metolazone—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Metolazone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Metolazone—Nausea—Melphalan—peripheral nervous system neoplasm	0.00107	0.00107	CcSEcCtD
Metolazone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Metolazone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Metolazone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Metolazone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Metolazone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Metolazone—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00104	0.00104	CcSEcCtD
Metolazone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Metolazone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Metolazone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Metolazone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Metolazone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00102	CcSEcCtD
Metolazone—Pain—Cisplatin—peripheral nervous system neoplasm	0.001	0.001	CcSEcCtD
Metolazone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.000989	CcSEcCtD
Metolazone—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000988	0.000988	CcSEcCtD
Metolazone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000978	0.000978	CcSEcCtD
Metolazone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000975	0.000975	CcSEcCtD
Metolazone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Metolazone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000968	0.000968	CcSEcCtD
Metolazone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000966	0.000966	CcSEcCtD
Metolazone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000962	0.000962	CcSEcCtD
Metolazone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000957	0.000957	CcSEcCtD
Metolazone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000956	0.000956	CcSEcCtD
Metolazone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000953	0.000953	CcSEcCtD
Metolazone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Metolazone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Metolazone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000943	0.000943	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Metolazone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000937	0.000937	CcSEcCtD
Metolazone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000935	0.000935	CcSEcCtD
Metolazone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Metolazone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Metolazone—Pain—Etoposide—peripheral nervous system neoplasm	0.00092	0.00092	CcSEcCtD
Metolazone—Constipation—Etoposide—peripheral nervous system neoplasm	0.00092	0.00092	CcSEcCtD
Metolazone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.000911	CcSEcCtD
Metolazone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000909	0.000909	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.000896	CcSEcCtD
Metolazone—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000892	0.000892	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000886	0.000886	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000885	0.000885	CcSEcCtD
Metolazone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000883	0.000883	CcSEcCtD
Metolazone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000882	0.000882	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00088	0.00088	CcSEcCtD
Metolazone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000878	0.000878	CcSEcCtD
Metolazone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000876	0.000876	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Metolazone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000869	0.000869	CcSEcCtD
Metolazone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000868	0.000868	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000867	0.000867	CcSEcCtD
Metolazone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Metolazone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.000858	CcSEcCtD
Metolazone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Metolazone—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000849	0.000849	CcSEcCtD
Metolazone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000844	0.000844	CcSEcCtD
Metolazone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000842	0.000842	CcSEcCtD
Metolazone—Rash—Vincristine—peripheral nervous system neoplasm	0.000837	0.000837	CcSEcCtD
Metolazone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000837	0.000837	CcSEcCtD
Metolazone—Headache—Vincristine—peripheral nervous system neoplasm	0.000832	0.000832	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000825	0.000825	CcSEcCtD
Metolazone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000819	0.000819	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000816	0.000816	CcSEcCtD
Metolazone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000803	0.000803	CcSEcCtD
Metolazone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000802	0.000802	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000793	0.000793	CcSEcCtD
Metolazone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000791	0.000791	CcSEcCtD
Metolazone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000785	0.000785	CcSEcCtD
Metolazone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000772	0.000772	CcSEcCtD
Metolazone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000762	0.000762	CcSEcCtD
Metolazone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000761	0.000761	CcSEcCtD
Metolazone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000747	0.000747	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Metolazone—Rash—Cisplatin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Metolazone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00074	0.00074	CcSEcCtD
Metolazone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000736	0.000736	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000732	0.000732	CcSEcCtD
Metolazone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000728	0.000728	CcSEcCtD
Metolazone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000725	0.000725	CcSEcCtD
Metolazone—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000724	0.000724	CcSEcCtD
Metolazone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Metolazone—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000715	0.000715	CcSEcCtD
Metolazone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Metolazone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00071	0.00071	CcSEcCtD
Metolazone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000705	0.000705	CcSEcCtD
Metolazone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000697	0.000697	CcSEcCtD
Metolazone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000696	CcSEcCtD
Metolazone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000686	0.000686	CcSEcCtD
Metolazone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Metolazone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000683	0.000683	CcSEcCtD
Metolazone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Metolazone—Rash—Etoposide—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Metolazone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Metolazone—Headache—Etoposide—peripheral nervous system neoplasm	0.000674	0.000674	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000674	0.000674	CcSEcCtD
Metolazone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000671	0.000671	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000669	CcSEcCtD
Metolazone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000666	0.000666	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000664	0.000664	CcSEcCtD
Metolazone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000664	0.000664	CcSEcCtD
Metolazone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Metolazone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Metolazone—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000661	0.000661	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.000657	CcSEcCtD
Metolazone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000653	0.000653	CcSEcCtD
Metolazone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000649	0.000649	CcSEcCtD
Metolazone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000645	0.000645	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000644	CcSEcCtD
Metolazone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Metolazone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000634	0.000634	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.000632	CcSEcCtD
Metolazone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Metolazone—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000629	0.000629	CcSEcCtD
Metolazone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
Metolazone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000627	CcSEcCtD
Metolazone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000621	0.000621	CcSEcCtD
Metolazone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000616	CcSEcCtD
Metolazone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000615	0.000615	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000614	0.000614	CcSEcCtD
Metolazone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000613	0.000613	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000612	0.000612	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000601	0.000601	CcSEcCtD
Metolazone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.000597	CcSEcCtD
Metolazone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000593	CcSEcCtD
Metolazone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.000582	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00058	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Metolazone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000575	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000569	0.000569	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Metolazone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Metolazone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Metolazone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000541	CcSEcCtD
Metolazone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000536	0.000536	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000532	CcSEcCtD
Metolazone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000531	CcSEcCtD
Metolazone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000524	0.000524	CcSEcCtD
Metolazone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00052	0.00052	CcSEcCtD
Metolazone—Pain—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Metolazone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000508	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000505	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000501	CcSEcCtD
Metolazone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000497	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.000496	CcSEcCtD
Metolazone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000493	0.000493	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000491	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000481	CcSEcCtD
Metolazone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Metolazone—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Metolazone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Metolazone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00046	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Metolazone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000444	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Metolazone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000433	CcSEcCtD
Metolazone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000427	0.000427	CcSEcCtD
Metolazone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000411	CcSEcCtD
Metolazone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.0004	CcSEcCtD
Metolazone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Metolazone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Metolazone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000383	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000382	CcSEcCtD
Metolazone—Rash—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Metolazone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Metolazone—Headache—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000378	CcSEcCtD
Metolazone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Metolazone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Metolazone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000355	CcSEcCtD
Metolazone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000351	CcSEcCtD
Metolazone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Metolazone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
